Skip to content
2000
Volume 21, Issue 6
  • ISSN: 1573-403X
  • E-ISSN: 1875-6557

Abstract

Background

Peripartum Cardiomyopathy (PPCM) is a rare yet fatal cardiac disease associated with pregnancy. PPCM has been shown to have similar etiopathogenesis with hypertensive disorders of pregnancy (HDP). Hence, this study aims to study the association between HDP and the development of PPCM.

Methods

Three databases (PubMed, Scopus, Cochrane Library) were searched and screened based on prespecified inclusion and exclusion criteria. Predictors of PPCM evaluated were HDP (preeclampsia, superimposed preeclampsia, chronic hypertension, and gestational hypertension) and its clinical features (severe preeclampsia, age, parity, serum creatinine, .). Data were analyzed using the random effects model of pooled odds ratios (ORs) with the Mantel Haenszel method, and publication bias was assessed with a funnel plot.

Results

A total of 13 observational studies with 11,951 PPCM cases from 7 countries were identified. All types of HDP were associated with significantly increased odds of developing PPCM, and severe preeclampsia was associated with the highest OR of 13.33 (CI: 5.95 - 29.83, 0.01). Additionally, superimposed preeclampsia, chronic hypertension, preeclampsia, and lastly gestational hypertension were associated with increased odds of PPCM with OR 5.77, 4.73, 4.70, and 3.13, respectively. Other clinical features being statistically significant for PPCM development included advanced age > 35 years and multiple pregnancies ( 0.05). No significant difference in creatinine level was found between PPCM and no PPCM group. No publication bias was found based on funnel plot assessment.

Conclusion

HDP, especially severe preeclampsia, is associated with increased odds of PPCM development; hence, a low threshold for PPCM screening in this high-risk group is required.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccr/10.2174/011573403X329136250116050817
2025-02-13
2025-12-08

  • From This Site

    /content/journals/ccr/10.2174/011573403X329136250116050817
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SimpsonC. MittalR. JainR. JainR. Peripartum cardiomyopathy: A review of current literature.Future Cardiol.202218433734310.2217/fca‑2021‑0045 35196861
     [Google Scholar]
  2. IorgoveanuC. ZaghloulA. AshwathM. Peripartum cardiomyopathy: A review.Heart Fail. Rev.20212661287129610.1007/s10741‑020‑10061‑x 34138401
     [Google Scholar]
  3. DavisM.B. AranyZ. McNamaraD.M. GolandS. ElkayamU. Peripartum cardiomyopathy.J. Am. Coll. Cardiol.202075220722110.1016/j.jacc.2019.11.014 31948651
     [Google Scholar]
  4. KamiyaC.A. KitakazeM. Ishibashi-UedaH. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. -Results from the Japanese Nationwide survey of peripartum cardiomyopathy-.Circ. J.20117581975198110.1253/circj.CJ‑10‑1214 21617320
     [Google Scholar]
  5. LibbyP. O bonow R, L Mann D, et al. Braunwald’s Heart Disease.12th edAmsterdam, NetherlandsElsevier20222034
     [Google Scholar]
  6. EjimE.C. KarayeK.M. AntiaS. IsiguzoG.C. NjokuP.O. Peripartum cardiomyopathy in low- and middle-income countries.Best Pract. Res. Clin. Obstet. Gynaecol.20249310247610.1016/j.bpobgyn.2024.102476 38395024
     [Google Scholar]
  7. GoliR. LiJ. BrandimartoJ. Genetic and phenotypic landscape of peripartum cardiomyopathy.Circulation2021143191852186210.1161/CIRCULATIONAHA.120.052395 33874732
     [Google Scholar]
  8. SliwaK. BauersachsJ. AranyZ. SpracklenT.F. Hilfiker-KleinerD. Peripartum cardiomyopathy: From genetics to management.Eur. Heart J.202142323094310210.1093/eurheartj/ehab458 34322694
     [Google Scholar]
  9. GolandS. ModiK. BitarF. Clinical profile and predictors of complications in peripartum cardiomyopathy.J. Card. Fail.200915864565010.1016/j.cardfail.2009.03.008 19786252
     [Google Scholar]
  10. BalaR. MehtaS. RoyV.C. KaurG. de MarvaoA. Peripartum cardiomyopathy: A review.Rev. Port. Cardiol.2023421191792410.1016/j.repc.2023.01.029 37414337
     [Google Scholar]
  11. JagodzińskaA. GondekA. PietrzakB. Cudnoch-JędrzejewskaA. MamcarzA. WielgośM. Peripartum cardiomyopathy – from pathogenesis to treatment.J. Perinat. Med.201846323724510.1515/jpm‑2016‑0247 28489560
     [Google Scholar]
  12. PattenI.S. RanaS. ShahulS. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.Nature2012485739833333810.1038/nature11040 22596155
     [Google Scholar]
  13. UkahU.V. De SilvaD.A. PayneB. Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review.Pregnancy Hypertens.2018111111512310.1016/j.preghy.2017.11.006 29198742
     [Google Scholar]
  14. PageM.J. McKenzieJ.E. BossuytP.M. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.BMJ2021372n7110.1136/bmj.n71 33782057
     [Google Scholar]
  15. WuP. GreenM. MyersJ.E. Hypertensive disorders of pregnancy.BMJ2023381e07165310.1136/bmj‑2022‑071653 37391211
     [Google Scholar]
  16. HuangW. NurhafizahA. FrederichA. Risk and protective factors of poor clinical outcomes in heart failure with improved ejection fraction population: A systematic review and meta-analysis.Curr. Cardiol. Rep.2025271410.1007/s11886‑024‑02180‑w 39760806
     [Google Scholar]
  17. HuangW FlindyS NurhafizahA NafisaKA FrederichA MarthaJW Percutaneous coronary intervention strategies in non-ST segment elevation acute coronary syndrome patients with multivessel coronary artery disease: Systematic review pairwise and network meta-analysis. Cardiovasc Revascul Med20241000910.1016/j.carrev.2024.10.009
     [Google Scholar]
  18. IsogaiT. KamiyaC.A. Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality.Int. Heart J.201960350351110.1536/ihj.18‑729 31019181
     [Google Scholar]
  19. ErsbøllA.S. GoetzeJ.P. JohansenM. Biomarkers and their relation to cardiac function late after peripartum cardiomyopathy.J. Card. Fail.202127216817510.1016/j.cardfail.2021.01.002 33422687
     [Google Scholar]
  20. MebazaaA. SerondeM.F. GayatE. Imbalanced angiogenesis in peripartum cardiomyopathy: {Diagnostic} value of placenta growth factor.Circ. J.201781111654166110.1253/circj.CJ‑16‑1193 28552862
     [Google Scholar]
  21. MelchiorreK. SharmaR. KhalilA. ThilaganathanB. Maternal cardiovascular function in normal pregnancy.Hypertension201667475476210.1161/HYPERTENSIONAHA.115.06667 26962206
     [Google Scholar]
  22. MelchiorreK. SutherlandG.R. Watt-CooteI. LiberatiM. ThilaganathanB. Severe myocardial impairment and chamber dysfunction in preterm preeclampsia.Hypertens. Pregnancy201231445447110.3109/10641955.2012.697951 23030711
     [Google Scholar]
  23. CunninghamC. RiveraJ. SpenceD. Severe preeclampsia, pulmonary edema, and peripartum cardiomyopathy in a primigravida patient.AANA J.2011793249255 21751694
     [Google Scholar]
  24. WuP. Chew-GrahamC.A. MaasA.H.E.M. Temporal changes in hypertensive disorders of pregnancy and impact on cardiovascular and obstetric outcomes.Am. J. Cardiol.2020125101508151610.1016/j.amjcard.2020.02.029 32273052
     [Google Scholar]
  25. PughD. DhaunN. Hypertension and vascular inflammation.Hypertension202177119019210.1161/HYPERTENSIONAHA.120.16420 33296247
     [Google Scholar]
  26. YangY. Le RayI. ZhuJ. ZhangJ. HuaJ. ReillyM. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China.JAMA Netw. Open202145e21840110.1001/jamanetworkopen.2021.8401 33970258
     [Google Scholar]
  27. ChangK.J. SeowK.M. ChenK.H. Preeclampsia: Recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition.Int. J. Environ. Res. Public Health2023204299410.3390/ijerph20042994 36833689
     [Google Scholar]
  28. SanusiM. MominE.S. MannanV. Using echocardiography and biomarkers to determine prognosis in peripartum cardiomyopathy: A systematic review.Cureus2022146e2613010.7759/cureus.26130 35875281
     [Google Scholar]
  29. KućA. KubikD. KościeleckaK. SzymanekW. Męcik-KronenbergT. The relationship between peripartum cardiomyopathy and preeclampsia – pathogenesis, diagnosis and management.J. Multidiscip. Healthc.20221585786710.2147/JMDH.S357872 35496718
     [Google Scholar]
  30. ParikhP. BlauwetL. Peripartum cardiomyopathy and preeclampsia: Overlapping diseases of pregnancy.Curr. Hypertens. Rep.20182086910.1007/s11906‑018‑0868‑9 29971645
     [Google Scholar]
  31. SonaglioniA. PuscaI. CasieriF. Echocardiographic assessment of left atrial mechanics in women with hypertensive disorders of pregnancy: A systematic review and meta-analysis.Eur. J. Obstet. Gynecol. Reprod. Biol.2024299627010.1016/j.ejogrb.2024.05.044 38838388
     [Google Scholar]
/content/journals/ccr/10.2174/011573403X329136250116050817
Loading
Association of Hypertensive Disorders of Pregnancy and their Clinical Features with Peripartum Cardiomyopathy: A Systematic Review and Meta-analysis
Curr. Cardiol. Rev. 21, e1573403X329136 (2025); https://doi.org/10.2174/011573403X329136250116050817
/content/journals/ccr/10.2174/011573403X329136250116050817
/content/journals/ccr/10.2174/011573403X329136250116050817
Loading

Data & Media loading...

Supplements

PRISMA checklist and supplementary material are available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): chronic hypertension; gestational hypertension; Hypertensive disorders of pregnancy; peripartum cardiomyopathy; preeclampsia; superimposed preeclampsia

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test